These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35733068)

  • 1. Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.
    Kiani-Zadeh M; Rezvany MR; Namjoo S; Barati M; Mohammadi MH; Ghasemi B; Tabatabaei T; Ghavamzadeh A; Zaker F; Teimoori-Toolabi L
    Mol Biol Rep; 2022 Aug; 49(8):7849-7862. PubMed ID: 35733068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
    Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
    Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
    Lian XY; Ma JC; Zhou JD; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Li XX; He PF; Yan Y; Lin J; Qian J
    J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
    Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
    Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
    Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methylation Status and mRNA Expression of DKK-3 and WIF-1 in Acute Myeloid Leukemia Patients].
    Xu MM; Yang YL; Geng YH; Li J; Ma Y; Zhang F; Zhu FB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1314-1320. PubMed ID: 29070101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.
    Hua KT; Lee WJ; Yang SF; Chen CK; Hsiao M; Ku CC; Wei LH; Kuo ML; Chien MH
    Biochim Biophys Acta; 2014 Feb; 1843(2):387-97. PubMed ID: 24184161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
    Zhang ZH; Zhang W; Zhou JD; Zhang TJ; Ma JC; Xu ZJ; Lian XY; Wu DH; Wen XM; Deng ZQ; Lin J; Qian J
    Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of PTGS2 promoter methylation in chronic periodontitis.
    Zhang S; Barros SP; Niculescu MD; Moretti AJ; Preisser JS; Offenbacher S
    J Dent Res; 2010 Feb; 89(2):133-7. PubMed ID: 20042743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital PCR-based
    Hua J; Chu M; Wang C; Zhang H; Luan J; Zhang Y; Li Q; Xiao T; Zhu C; Li X; Fu B
    Epigenomics; 2024 Feb; 16(4):233-247. PubMed ID: 38343387
    [No Abstract]   [Full Text] [Related]  

  • 18. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
    Lenz G; Hutter G; Hiddemann W; Dreyling M
    Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia.
    Nan FY; Gu Y; Xu ZJ; Sun GK; Zhou JD; Zhang TJ; Ma JC; Leng JY; Lin J; Qian J
    Cancer Med; 2021 Aug; 10(15):5283-5296. PubMed ID: 34227248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between IL-7 genomic protein methylation level and acute myeloid leukemia.
    Li ZH; Liu Y; Gao SY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1196-1202. PubMed ID: 30779089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.